Description
Don’t miss this exciting opportunity to hear from Insulet's Senior Vice President and Chief Medical Officer, Dr. Trang Ly, along with investigators from the Omnipod 5 SECURE-T2D clinical study. Whether you're looking to enhance outcomes for your insulin-requiring type 2 diabetes patients or be at the forefront of innovation, this webinar will provide you with valuable insights and actionable knowledge to help advance patient care.
During this webinar, the panel of experts will share:
• Insights into the evolving type 2 diabetes landscape
• Why Omnipod 5 SECURE-T2D was called a "breakthrough study"
• Groundbreaking outcomes that made Omnipod 5 the first and only automated insulin delivery system indicated for adults with type 2 diabetes in the U.S.
This
45-minute activity was originally presented on 10/9/2024.
Sponsor
This
recorded webinar is sponsored by Insulet.
Intended
Audience
This
activity is designed for diabetes care and education specialists, including
nurses, dietitians, pharmacists, nurse practitioners, clinical nurse
specialists, PAs, physicians, and other health care providers interested in
staying up to date on current practices of care for people with diabetes and
other related conditions.
Disclaimer
This educational program does not provide certification on the product discussed. There is no CE/CME credit for this activity.
Refer to the Omnipod 5 Automated Insulin Delivery System User Guide at www.omnipod.com/safety for complete safety information including indications, contraindications, warnings, cautions, and instructions.
Pricing
This
recorded webinar is FREE for ADCES members and non-members.
Access
Period
You
will have access to this training for a period of six months after you enroll,
or when the activity expires on 11/11/2026 (whichever comes first).